The crucial role of PARP1 in DNA repair renders PARP1 a valuable target in cancer therapy, as PARP inhibitors increase the sensitivity of tumor cells to DNA damaging agents, especially those cells that are defective in homologous recombination repair. This evidence concerns the gene PARP1 and neoplasm.